Literature DB >> 31236637

High-flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: author's reply.

Bram Rochwerg1,2,3, D Granton4, D X Wang5, S Einav6,7, K E A Burns8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31236637     DOI： 10.1007/s00134-019-05658-2

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  2 in total

1.  High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure.

Authors:  Meng-Si Luo; Guan-Jiang Huang; Lun Wu
Journal:  Intensive Care Med       Date:  2019-06-03       Impact factor: 17.440

Review 2.  High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis.

Authors:  B Rochwerg; D Granton; D X Wang; Y Helviz; S Einav; J P Frat; A Mekontso-Dessap; A Schreiber; E Azoulay; A Mercat; A Demoule; V Lemiale; A Pesenti; E D Riviello; T Mauri; J Mancebo; L Brochard; K Burns
Journal:  Intensive Care Med       Date:  2019-03-19       Impact factor: 17.440
  2 in total
  6 in total

1.  Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

Authors:  Laura Evans; Andrew Rhodes; Waleed Alhazzani; Massimo Antonelli; Craig M Coopersmith; Craig French; Flávia R Machado; Lauralyn Mcintyre; Marlies Ostermann; Hallie C Prescott; Christa Schorr; Steven Simpson; W Joost Wiersinga; Fayez Alshamsi; Derek C Angus; Yaseen Arabi; Luciano Azevedo; Richard Beale; Gregory Beilman; Emilie Belley-Cote; Lisa Burry; Maurizio Cecconi; John Centofanti; Angel Coz Yataco; Jan De Waele; R Phillip Dellinger; Kent Doi; Bin Du; Elisa Estenssoro; Ricard Ferrer; Charles Gomersall; Carol Hodgson; Morten Hylander Møller; Theodore Iwashyna; Shevin Jacob; Ruth Kleinpell; Michael Klompas; Younsuck Koh; Anand Kumar; Arthur Kwizera; Suzana Lobo; Henry Masur; Steven McGloughlin; Sangeeta Mehta; Yatin Mehta; Mervyn Mer; Mark Nunnally; Simon Oczkowski; Tiffany Osborn; Elizabeth Papathanassoglou; Anders Perner; Michael Puskarich; Jason Roberts; William Schweickert; Maureen Seckel; Jonathan Sevransky; Charles L Sprung; Tobias Welte; Janice Zimmerman; Mitchell Levy
Journal:  Intensive Care Med       Date:  2021-10-02       Impact factor: 17.440

2.  The utility of high-flow nasal oxygen for severe COVID-19 pneumonia in a resource-constrained setting: A multi-centre prospective observational study.

Authors:  Gregory L Calligaro; Usha Lalla; Gordon Audley; Phindile Gina; Malcolm G Miller; Marc Mendelson; Sipho Dlamini; Sean Wasserman; Graeme Meintjes; Jonathan Peter; Dion Levin; Joel A Dave; Ntobeko Ntusi; Stuart Meier; Francesca Little; Desiree L Moodley; Elizabeth H Louw; Andre Nortje; Arifa Parker; Jantjie J Taljaard; Brian W Allwood; Keertan Dheda; Coenraad F N Koegelenberg
Journal:  EClinicalMedicine       Date:  2020-10-06

3.  High flow nasal cannula useful for severe SARSs-CoV-2 pneumonia.

Authors:  V E Ángel Mejía; D Arango Isaza; M J Fernández Turizo; E M Vasquez Trespalacios; J A Rincón
Journal:  Med Intensiva (Engl Ed)       Date:  2021-02-10

4.  Utility of the ROX Index in Predicting Intubation for Patients With COVID-19-Related Hypoxemic Respiratory Failure Receiving High-Flow Nasal Therapy: Retrospective Cohort Study.

Authors:  Maulin Patel; Junad Chowdhury; Nicole Mills; Robert Marron; Andrew Gangemi; Zachariah Dorey-Stein; Ibraheem Yousef; Matthew Zheng; Lauren Tragesser; Julie Giurintano; Rohit Gupta; Parth Rali; Gilbert D'Alonzo; Huaqing Zhao; Nicole Patlakh; Nathaniel Marchetti; Gerard Criner; Matthew Gordon
Journal:  JMIRx Med       Date:  2021-08-27

Review 5.  High-Flow Nasal Oxygenation and Its Applicability in COVID Patients.

Authors:  Raafay Mehmood; Zainab Mansoor; Gabriel Plamenov Atanasov; Alexei Cheian; Alina Davletova; Aman Patel; Danial Ahmed
Journal:  SN Compr Clin Med       Date:  2022-01-31

6.  High flow nasal cannula useful for severe SARSs-CoV-2 pneumonia.

Authors:  V E Ángel Mejía; D Arango Isaza; M J Fernández Turizo; E M Vasquez Trespalacios; J A Rincón
Journal:  Med Intensiva (Engl Ed)       Date:  2022-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.